// App-Quantinova.ai

P330 : Discontinuation of corticosteroids among ulcerative colitis patients treated with vedolizumab in the United States

Researchers

Presenter

  • H. Patel

Principal Investigators

  • B. Chastek

  • K.D. Null

  • D. Demuth

Medical Centers

  • Immensity Consulting, Inc, , Chicago, United States

  • Optum, Eden Prairie, United States

  • Takeda Pharmaceuticals U.S.A., Inc., Health Economics and Outcomes Research, Deerfield, United States

  • Takeda Development Centre Europe Ltd., Evidence and Value Generation, London, UK

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Takeda Pharmaceutical Company

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved